Products
Investing
Resources
Credit Cards
Tools & Calculators
Support
AstraZeneca Pharma India Limited (ASTRAZEN)
₹7,733.25
INR-74.10(-0.95%)
As of March 12, 2025 9:20:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹19518.38 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹19038.71 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
200.75
Forward P/E
Price to Earnings ratio based on forecasted earnings
NA
PEG Ratio
Price/Earnings to Growth ratio
3.20
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
12.06
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
43.89%
Operating Margin
Operating income as a percentage of revenue
15.43%
Return on Equity
Net income as a percentage of shareholders' equity
22.69%
Revenue (TTM)
Total revenue over trailing 12 months
₹1619.01 Cr+44%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹251.34 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹38.89+95.19999999999999%
Balance Sheet
Total Cash
Total cash and short-term investments
₹496.78 Cr
Total Debt
Total short-term and long-term debt
₹17.12 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
2.52%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹4785 - ₹8139
Beta
Measure of stock's volatility compared to the market
0.33
Shares Outstanding
Total number of shares issued by the company
₹2.50 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
0.31%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
NA
Payout Ratio
Percentage of earnings paid as dividends
61.89%